Health Status and Health Care Costs for Publicly Funded Patients With Schizophrenia Started on Clozapine
- 1 December 1998
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 49 (12) , 1590-1593
- https://doi.org/10.1176/ps.49.12.1590
Abstract
The study examined the effect of clozapine treatment on the health care costs and health status of people with schizophrenia who are supported by public funds.Keywords
This publication has 14 references indexed in Scilit:
- A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory SchizophreniaNew England Journal of Medicine, 1997
- Patient response and resource management: another view of clozapine treatment of schizophreniaAmerican Journal of Psychiatry, 1995
- Savings in Hospital Bed-Days Related to Treatment With ClozapinePsychiatric Services, 1994
- Cost effectiveness of clozapine in neuroleptic-resistant schizophreniaAmerican Journal of Psychiatry, 1993
- Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health CouncilAmerican Journal of Psychiatry, 1993
- The Costs of Schizophrenia: Assessing the BurdenPsychiatric Clinics of North America, 1993
- Cost-Effectiveness of Clozapine for Treatment-Resistant Schizophrenic PatientsPsychiatric Services, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit SyndromeSchizophrenia Bulletin, 1984
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967